Lisa Y. Foo - 27 Feb 2026 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 20:00:14 UTC
Prior SEC filing
26 Feb 2026
Next SEC filing
31 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo

Key filing fact

Lisa Y. Foo filed Form 4 for TENET HEALTHCARE CORP (THC) on 03 Mar 2026.

Key facts

  • This page summarizes Lisa Y. Foo's Form 4 filing for TENET HEALTHCARE CORP (THC).
  • 8 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2026, 20:00.

Change

  • Previous filing in this sequence was filed on 26 Feb 2026.
  • Current net transaction value: -$4,744,495.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916153 Primary reporting owner

Foo Lisa Y

Relationship
EVP, Chief Operating Officer
Address
14201 DALLAS PARKWAY, DALLAS
Signature
Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

THC transaction

Common Stock

Options Exercise

Transaction value
Shares
+4,670
Change %
+8.8%
Price
Shares after
57,687
Date
27 Feb 2026
Ownership
Direct
Footnotes
F1
THC transaction

Common Stock

Options Exercise

Transaction value
Shares
+4,199
Change %
+7.3%
Price
Shares after
61,886
Date
27 Feb 2026
Ownership
Direct
Footnotes
F1
THC transaction

Common Stock

Tax liability

Transaction value
$436,672
Shares
-1,838
Change %
-3%
Price
$237.58
Shares after
60,048
Date
27 Feb 2026
Ownership
Direct
Footnotes
F2, F3
THC transaction

Common Stock

Tax liability

Transaction value
$1,026,744
Shares
-4,289
Change %
-7.1%
Price
$239.39
Shares after
55,759
Date
27 Feb 2026
Ownership
Direct
Footnotes
F4, F5
THC transaction

Common Stock

Tax liability

Transaction value
$3,281,079
Shares
-13,706
Change %
-25%
Price
$239.39
Shares after
42,053
Date
27 Feb 2026
Ownership
Direct
Footnotes
F2, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THC transaction Derivative

2026 February Restricted Stock Units

Award

Transaction value
$0
Shares
+7,520
Change %
Price
$0.000000
Shares after
7,520
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,520
Exercise price
Footnotes
F6
THC transaction Derivative

2024 February Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,670
Change %
-50%
Price
$0.000000
Shares after
4,671
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,670
Exercise price
Footnotes
F7, F8
THC transaction Derivative

2023 March Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,199
Change %
-100%
Price
$0.000000
Shares after
0
Date
27 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,199
Exercise price
Footnotes
F8, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.

Footnote F3

Represents the closing price of the common stock of the Issuer on the vesting date for the award.

Footnote F4

Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Footnote F5

Represents the closing price of the common stock of the Issuer on February 27, 2026.

Footnote F6

These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.

Footnote F7

The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).

Footnote F8

Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Footnote F9

The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .